IDEAYA Biosciences
Tori D. currently serves as the Manager of SEC Reporting and Technical Accounting at IDEAYA Biosciences, a role undertaken since November 2023. Prior experience includes a tenure at EY from September 2018 to November 2023, where Tori progressed from Assurance Staff to Assurance Manager, focusing on a variety of industries such as Technology, Life Science, Media, and Aerospace & Defense. Key responsibilities included overseeing SOX 404 compliance testing, conducting substantive procedures for financial statement accounts, utilizing data analytic tools for enhanced testing programs, and assisting with the IPO process of a life science client. Tori also has experience with ERP transitions and various IT systems. Tori's academic background includes a Bachelor's Degree in Economics and Accounting from UC Santa Barbara, along with a brief study period at Universidad Nebrija and foundational education at Palo Alto High School.
This person is not in any teams
This person is not in any offices
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California